top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
An Act to Amend the Federal Food, Drug, and Cosmetic Act with Respect to Human Drug Compounding and Drug Supply Chain Security, and for Other Purposes
An Act to Amend the Federal Food, Drug, and Cosmetic Act with Respect to Human Drug Compounding and Drug Supply Chain Security, and for Other Purposes
Pubbl/distr/stampa [Washington, D.C.] : , : [U.S. Government Printing Office], , [2013]
Descrizione fisica 1 online resource (54 unnumbered pages)
Soggetto topico Pharmaceutical industry - United States - Quality control
Pharmaceutical industry - Security measures - United States
Drugs - Dosage forms - United States - Quality control
Drug adulteration - United States - Prevention
Drugs - Marketing - Corrupt practices - United States - Prevention
Product counterfeiting - United States - Prevention
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910704917503321
[Washington, D.C.] : , : [U.S. Government Printing Office], , [2013]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001
Continuing concerns over imported pharmaceuticals : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, first session, June 7, 2001
Pubbl/distr/stampa Washington : , : U.S. Government Printing Office, , 2001
Descrizione fisica 1 online resource (iii, 191 pages) : illustrations
Soggetto topico Drugs - Inspection - United States
Drug adulteration - Government policy - United States
Pharmaceutical industry - United States - Quality control
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Continuing concerns over imported pharmaceuticals
Record Nr. UNINA-9910708356803321
Washington : , : U.S. Government Printing Office, , 2001
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Counterfeit bulk drugs : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000
Counterfeit bulk drugs : hearings before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Sixth Congress, second session, June 8 and October 3, 2000
Pubbl/distr/stampa Washington : , : U.S. Government Printing Office, , 2000
Descrizione fisica 1 online resource (iii, 423 pages) : illustrations
Soggetto topico Drugs - Inspection - United States
Drugs - Standards - United States
Drug adulteration - Government policy - United States
Pharmaceutical industry - United States - Quality control
Product counterfeiting - United States
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Counterfeit bulk drugs
Record Nr. UNINA-9910706954803321
Washington : , : U.S. Government Printing Office, , 2000
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug compounding pharmacies : risk and oversight issues / / Seth Sharpe, editor
Drug compounding pharmacies : risk and oversight issues / / Seth Sharpe, editor
Pubbl/distr/stampa [Hauppauge] New York : , : Nova Publishers, , [2013]
Descrizione fisica 1 online resource (184 pages)
Disciplina 338.4/76151
Collana Pharmacology, research, safety testing and regulation
Public health in the 21st century
Soggetto topico Pharmaceutical technology - Standards
Pharmaceutical industry - United States - Quality control
Products liability - Drugs - United States
ISBN 1-62808-177-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910151722103321
[Hauppauge] New York : , : Nova Publishers, , [2013]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The FDA and worldwide current good manufacturing practices and quality system requirements guidebook for finished pharmaceuticals / / José Rodríguez-Pérez
The FDA and worldwide current good manufacturing practices and quality system requirements guidebook for finished pharmaceuticals / / José Rodríguez-Pérez
Autore Rodríguez Pérez José <1961->
Pubbl/distr/stampa Milwaukee, Wisconsin : , : ASQ Quality Press, , [2014]
Descrizione fisica 1 online resource (391 pages)
Disciplina 338.476151
Soggetto topico Pharmaceutical industry - United States - Quality control
Pharmaceutical industry - Production standards - United States
Drugs - Standards
ISBN 0-87389-828-1
0-87389-829-X
1-68015-784-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910797541903321
Rodríguez Pérez José <1961->  
Milwaukee, Wisconsin : , : ASQ Quality Press, , [2014]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The FDA and worldwide current good manufacturing practices and quality system requirements guidebook for finished pharmaceuticals / / José Rodríguez-Pérez
The FDA and worldwide current good manufacturing practices and quality system requirements guidebook for finished pharmaceuticals / / José Rodríguez-Pérez
Autore Rodríguez Pérez José <1961->
Pubbl/distr/stampa Milwaukee, Wisconsin : , : ASQ Quality Press, , [2014]
Descrizione fisica 1 online resource (391 pages)
Disciplina 338.476151
Soggetto topico Pharmaceutical industry - United States - Quality control
Pharmaceutical industry - Production standards - United States
Drugs - Standards
ISBN 0-87389-828-1
0-87389-829-X
1-68015-784-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910814801203321
Rodríguez Pérez José <1961->  
Milwaukee, Wisconsin : , : ASQ Quality Press, , [2014]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Federal and state role in pharmacy compounding and reconstitution : exploring the right mix to protect patients : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session, on examining state and federal oversight to ensure the safety and quality of drug compounding--the process of mixing, combining, or altering ingredients to create a customized medication for an individual patient--by pharmacies, October 23, 2003
Federal and state role in pharmacy compounding and reconstitution : exploring the right mix to protect patients : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session, on examining state and federal oversight to ensure the safety and quality of drug compounding--the process of mixing, combining, or altering ingredients to create a customized medication for an individual patient--by pharmacies, October 23, 2003
Descrizione fisica 1 online resource (iii, 145 p.) : ill
Soggetto topico Drugs - Dosage forms - United States - Evaluation
Pharmaceutical industry - United States - Quality control
Soggetto non controllato Drugs
Pharmaceutical industry
Medical
Business & economics
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Federal and state role in pharmacy compounding and reconstitution
Record Nr. UNINA-9910689604203321
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Guidance for industry [[electronic resource] ] : Q10 pharmaceutical quality system
Guidance for industry [[electronic resource] ] : Q10 pharmaceutical quality system
Pubbl/distr/stampa Silver Spring, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research
Descrizione fisica i, 19 pages : digital, PDF file
Soggetto topico Pharmaceutical industry - United States - Quality control
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Guidance for industry
Record Nr. UNINA-9910698894403321
Silver Spring, MD : , : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Pubbl/distr/stampa Washington, District of Columbia : , : National Academies Press, , [2012]
Descrizione fisica 1 online resource (132 p.)
Disciplina 615.1/9
Soggetto topico Drug monitoring
Drug development - United States
Drugs - United States - Design
Pharmaceutical industry - United States - Quality control
Soggetto genere / forma Electronic books.
ISBN 0-309-26117-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN.
Record Nr. UNINA-9910463950903321
Washington, District of Columbia : , : National Academies Press, , [2012]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Pubbl/distr/stampa Washington, District of Columbia : , : National Academies Press, , [2012]
Descrizione fisica 1 online resource (132 p.)
Disciplina 615.1/9
Soggetto topico Drug monitoring
Drug development - United States
Drugs - United States - Design
Pharmaceutical industry - United States - Quality control
ISBN 0-309-26119-8
0-309-26117-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN.
Record Nr. UNINA-9910787308103321
Washington, District of Columbia : , : National Academies Press, , [2012]
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui